Hypoglycemic activities of MTP-3631 a novel thiopyranopyrimidine derivative
Authors:
- 31 December 1992
- journal article
- Published by Elsevier in Life Sciences
- Vol. 50 (5) , 375-381
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Actions of novel antidiabetic agent englitazone in hyperglycemic hyperinsulinemic ob/ob miceDiabetes, 1990
- Selective Potentiation of 5-Methyl-2-(1-Methylcyclohexyl)-4-Oxazoleacetic Acid (AD-4610) on Glucose-Induced Insulin SecretionHormone and Metabolic Research, 1988
- MTP-1307, a novel antidiabetic agent, improves the glucose intolerance of viable yellow obese-diabetic miceLife Sciences, 1987
- Synthesis and hypoglycemic activity of 7,8-dihydro-6H-thiopyrano(3,2-d)pyrimidine derivatives and related compounds.Chemical and Pharmaceutical Bulletin, 1986
- Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of actionDiabetes, 1984
- Extrapancreatic effects of sulfonylureasThe American Journal of Medicine, 1983
- In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport.Journal of Clinical Investigation, 1981
- Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors.Journal of Clinical Investigation, 1980
- A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agentDiabetes, 1978
- Clinical Pharmacology of Oral Antidiabetic AgentsNew England Journal of Medicine, 1977